Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: The Effect of Neurodynamic Mobilization Exercise on Lower Limb Pain in Patients With Rheumatoid Arthritis. [NA]
A clinical trial is evaluating whether neurodynamic mobilization exercises can reduce lower limb pain in rheumatoid arthritis patients; the …
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA
Real-world, observational evaluation of Canadians with moderate-to-severe rheumatoid arthritis treated with Humira. The study has completed …
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 trial evaluating the long-term efficacy of iguratimod, alone or in combination with methotrexate, in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: NFKB1 and IKK Epsilon in Rheumatoid Arthritis
The clinical trial investigating NFKB1 and IKK epsilon in rheumatoid arthritis has completed; the provided snippet does not include trial re…
-
FDA approval · 2016-02-22FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi Aria (golimumab) from Janssen Biotech, Inc., under BLA125433, to update the product …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis
An observational study evaluating the safety and effectiveness of rituximab in patients with severe active rheumatoid arthritis; results wer…
-
CLINICAL_TRIALS withdrawal · 2016-02-19Clinical Trial Update: Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA
An AbbVie-sponsored real-life study evaluating Humira (adalimumab) in Israeli rheumatoid arthritis patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II) [Phase 2]
Phase 2 trial AUGUST II evaluated atacicept in TNF-alpha–naïve rheumatoid arthritis patients; the study is completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I) [Phase 2]
This update reports results from a Phase 2 dose-finding study of atacicept in rheumatoid arthritis. The trial, sponsored by EMD Serono, has …
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study [Phase 3]
This entry describes a Phase 3 clinical trial comparing BOW015 (Infliximab-EPIRUS) with infliximab in patients with active rheumatoid arthri…
-
FDA approval · 2016-02-15FDA Approved: LEFLUNOMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Leflunomide filed by Chartwell RX, LLC under an active ANDA.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Robotic Arm Assisted Total Knee Arthroplasty [NA]
The document reports completion of a MAKO Surgical Corp. trial evaluating robotic arm–assisted total knee arthroplasty, with results posted …
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
This document reports the completion and results posting of a global comparative observational study evaluating tocilizumab (RoActemra/Actem…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
An observational study describing real-world patterns of biological DMARD use in rheumatoid arthritis patients. Sponsored by Hoffmann-La Roc…
-
FDA approval · 2016-02-08FDA Approved: IBUPROFEN — Supplemental Application (TIME CAP LABORATORIES,INC)
FDA approved a supplemental application for ibuprofen tablets from Time Cap Laboratories, Inc.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
The study reports patient-reported efficacy of subcutaneous abatacept in rheumatoid arthritis from a completed clinical trial conducted in S…
-
CLINICAL_TRIALS withdrawal · 2016-02-05Clinical Trial Update: Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA [Phase 2]
A Phase 2 study evaluating concomitant apremilast for active rheumatoid arthritis in patients on TNF inhibitors and methotrexate has been wi…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Factors Associated With Biologic DMARD Switching
Completed clinical trial that analyzed factors associated with switching between biologic DMARDs in rheumatoid arthritis patients. The study…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis
This completed observational trial examined the prevalence of dry eye disease in patients with rheumatoid arthritis. Results were posted on …
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients [Phase 1]
Phase 1 trial evaluating the effect of BMS-986142 on the pharmacokinetics of methotrexate and a probe substrate cocktail in healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: First-in-Human Single Ascending Dose of SHR0302 [Phase 1]
Phase 1 first-in-human single ascending dose study of SHR0302 in rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2016-01-25Clinical Trial Update: Rheumatic Diseases and Computer Use
A completed clinical trial update from the University of Pittsburgh examining the relationship between computer use and rheumatic diseases, …
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants [Phase 2]
Phase 2 clinical trial assessing the safety and efficacy of BG9924 in participants with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861) [Phase 2]
Phase 2 extension study of BG9924 in combination with methotrexate for rheumatoid arthritis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants [Phase 2]
Phase 2 trial of BG9924 in rheumatoid arthritis was terminated. The document reports safety and efficacy assessments from the trial.